Wolverine Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-21,256
| Closed | -$4.33M | – | 1594 |
|
|
2025
Q2 | $3.95M | Buy |
21,256
+19,778
| +1,338% | +$3.68M | 0.04% | 387 |
|
|
2025
Q1 | $310K | Sell |
1,478
-4,001
| -73% | -$778K | ﹤0.01% | 943 |
|
|
2024
Q4 | $974K | Buy |
+5,479
| New | +$1.01M | 0.01% | 704 |
|
|
2024
Q3 | – | Sell |
-808
| Closed | -$151K | – | 1643 |
|
|
2024
Q2 | $139K | Buy |
+808
| New | +$134K | ﹤0.01% | 1052 |
|
|
2023
Q4 | – | Sell |
-13,583
| Closed | -$1.98M | – | 1776 |
|
|
2023
Q3 | $2.02M | Sell |
13,583
-44,172
| -76% | -$6.48M | 0.02% | 542 |
|
|
2023
Q2 | $7.78M | Buy |
57,755
+40,712
| +239% | +$5.97M | 0.09% | 220 |
|
|
2023
Q1 | $2.72M | Buy |
+17,043
| New | +$2.61M | 0.03% | 456 |
|
|
2021
Q2 | – | Sell |
-792
| Closed | -$85K | – | 2135 |
|
|
2021
Q1 | $85K | Buy |
+792
| New | +$84.7K | ﹤0.01% | 1493 |
|
|
2018
Q2 | – | Sell |
-42,269
| Closed | -$4M | – | 1367 |
|
|
2018
Q1 | $4M | Buy |
42,269
+2,269
| +6% | +$249K | 0.05% | 314 |
|
|
2017
Q4 | $3.87M | Sell |
40,000
-20,988
| -34% | -$1.98M | 0.04% | 337 |
|
|
2017
Q3 | $5.42M | Buy |
60,988
+50,787
| +498% | +$3.87M | 0.06% | 246 |
|
|
2017
Q2 | $739K | Buy |
+10,201
| New | +$686K | 0.01% | 698 |
|
|
2016
Q4 | – | Sell |
-6,263
| Closed | -$382K | – | 1162 |
|
|
2016
Q3 | $395K | Sell |
6,263
-8,900
| -59% | -$576K | 0.01% | 740 |
|
|
2016
Q2 | $938K | Sell |
15,163
-3,500
| -19% | -$213K | 0.01% | 586 |
|
|
2016
Q1 | $1.07M | Buy |
18,663
+2,500
| +15% | +$139K | 0.03% | 382 |
|
|
2015
Q4 | $957K | Buy |
16,163
+6,150
| +61% | +$354K | 0.02% | 502 |
|
|
2015
Q3 | $544K | Sell |
10,013
-10,900
| -52% | -$710K | 0.01% | 654 |
|
|
2015
Q2 | $1.41M | Buy |
20,913
+5,913
| +39% | +$386K | 0.03% | 391 |
|
|
2015
Q1 | $878K | Buy |
+15,000
| New | +$906K | 0.02% | 476 |
|
|
2014
Q4 | – | Sell |
-2,700
| Closed | -$170K | – | 2099 |
|
|
2014
Q3 | $155K | Sell |
2,700
-3,331
| -55% | -$185K | ﹤0.01% | 1159 |
|
|
2014
Q2 | $340K | Buy |
6,031
+5,731
| +1,910% | +$301K | 0.01% | 732 |
|
|
2014
Q1 | $15K | Sell |
300
-18,102
| -98% | -$915K | ﹤0.01% | 1704 |
|
|
2013
Q4 | $971K | Buy |
18,402
+919
| +5% | +$45.2K | 0.02% | 527 |
|
|
2013
Q3 | $782K | Buy |
17,483
+11,700
| +202% | +$519K | 0.02% | 617 |
|
|
2013
Q2 | $239K | Buy |
+5,783
| New | +$253K | 0.01% | 1045 |
|
Other funds holding ABBV
VCM
VPM
Wolverine Asset Management's ABBV Position: Q3 2025 in Review
Wolverine Asset Management sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 21,256 shares — an estimated $4.33M sold.
Wolverine Asset Management first reported a position in ABBV in Q2 2013 and held it in 25 quarters. The position peaked at $7.78M in Q2 2023. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.
- Wolverine Asset Management reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
- Wolverine Asset Management sold 21,256 AbbVie shares in Q3 2025, an estimated $4.33M.
- Wolverine Asset Management first reported a position in AbbVie in Q2 2013 and held it in 25 quarters.
- Wolverine Asset Management's AbbVie position peaked at $7.78M in Q2 2023.
- 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.
Based on Wolverine Asset Management's 13F filing for Q3 2025, filed 28 Oct 2025.